Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women

By Reinier Kyndaron   Vacek Pamela   Geller Berta  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 343-348

Springer Publishing Company

Access to resources Recommend Favorite

NSAID use and survival after breast cancer diagnosis in post-menopausal women

By Blair Cindy   Sweeney Carol   Anderson Kristin   Folsom Aaron  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Cognitive function, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 131-132

Informa Healthcare

Access to resources Recommend Favorite

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study

By Schilder Christina   Eggens Petronella   Seynaeve Caroline   Linn Sabine   Boogerd Willem   Gundy Chad   Beex Louk   Van Dam Frits   Schagen Sanne  

Acta Oncologica, Vol. 48, Iss. 1, 2009-01 ,pp. : 76-85

Informa Healthcare

Access to resources Recommend Favorite

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

By Mar Fan Helen  

Supportive Care in Cancer, Vol. 16, Iss. 6, 2008-06 ,pp. : 577-583

Springer Publishing Company

Access to resources Recommend Favorite